CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 119 filers reported holding CRINETICS PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,513 | -43.2% | 1,564 | -65.6% | 0.00% | -66.7% |
| Q2 2023 | $81,883 | +264038.7% | 4,544 | +135.8% | 0.00% | +200.0% |
| Q1 2023 | $31 | +82.4% | 1,927 | +109.9% | 0.00% | 0.0% |
| Q4 2022 | $17 | -100.0% | 918 | -91.0% | 0.00% | -66.7% |
| Q3 2022 | $200,000 | +138.1% | 10,189 | +126.3% | 0.00% | +50.0% |
| Q2 2022 | $84,000 | -77.2% | 4,502 | -73.1% | 0.00% | -50.0% |
| Q1 2022 | $368,000 | +268.0% | 16,744 | +376.0% | 0.00% | +100.0% |
| Q4 2021 | $100,000 | +26.6% | 3,518 | -6.6% | 0.00% | 0.0% |
| Q3 2021 | $79,000 | +119.4% | 3,765 | +99.8% | 0.00% | +100.0% |
| Q2 2021 | $36,000 | +260.0% | 1,884 | +189.4% | 0.00% | – |
| Q1 2021 | $10,000 | -88.4% | 651 | -89.3% | 0.00% | -100.0% |
| Q4 2020 | $86,000 | -76.0% | 6,073 | -73.5% | 0.00% | -25.0% |
| Q3 2020 | $359,000 | +519.0% | 22,884 | +593.0% | 0.00% | +100.0% |
| Q2 2020 | $58,000 | +45.0% | 3,302 | +22.7% | 0.00% | -33.3% |
| Q3 2019 | $40,000 | +233.3% | 2,691 | +441.4% | 0.00% | +200.0% |
| Q2 2019 | $12,000 | -50.0% | 497 | -53.5% | 0.00% | 0.0% |
| Q1 2019 | $24,000 | -55.6% | 1,069 | -40.9% | 0.00% | -75.0% |
| Q4 2018 | $54,000 | – | 1,808 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
| Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
| Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
| Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
| 5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
| First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
| BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
| BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
| Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |